Skip to content
Division of Energy Employees Occupational Illness Compensation (DEEOIC)
Site Navigation
  • Home

DEEOIC Webinar Series:
Establishing Survivorship Under Part B and Part E

January 27, 2021
2:00 – 3:30 p.m. EST


NOTE: registration is closed

Overview

The Office of Workers’ Compensation Programs, Division of Energy Employees Occupational Illness Compensation (DEEOIC) invites you to a webinar discussion on Establishing Survivorship Under Part B and Part E of the Energy Employees Occupational Illness Compensation Program Act (EEOICPA).

This webinar series is an opportunity to hear from DEEOIC representatives. Representatives will discuss benefits available to eligible survivors under the EEOICPA. The webinar will conclude with answers to your questions. You can submit questions during the webinar or in advance at DEEOIC-Outreach@dol.gov.

The presentation will cover:

  • Overview of Survivorship
  • Eligibility Criteria under Part B and Part E
  • Compensation Under Part B and Part E
  • Multiple Survivor Award
  • Radiation Exposure Compensation Act Beneficiaries

Moderators/Presenters

  • Betty Gambill, Supervisory Claims Examiner, U.S. Department of Labor, DEEOIC
  • Kelly Allen, Technical Assistant, U.S. Department of Labor, DEEOIC

The Energy Employees Occupational Illness Compensation Program Act provides lump-sum compensation and medical benefits to current and former nuclear weapons workers whose illness is a result of working in the nuclear weapons industry. Survivors of qualified workers may also be entitled to benefits. Covered illnesses include radiation-induced cancer, chronic beryllium disease, beryllium sensitivity, chronic silicosis, or any illness due to exposure to toxic substances.

Questions

We will be conducting the webinar using WebEx. You will receive details on accessing this webinar as we get closer to the program.

If you have any questions on logistics or using WebEx, please contact our logistics manager, Annette Summers at Email: deeoic@thegateam.com Phone: 202-547-6340.